# Bioequivalence Study of SPARC147609 in Patients With Ovarian Cancer

> **NCT00862355** · PHASE1 · COMPLETED · sponsor: **Sun Pharma Advanced Research Company Limited** · enrollment: 24 (actual)

## Conditions studied

- Ovarian Carcinoma

## Interventions

- **DRUG:** SPARC147609
- **DRUG:** Reference147609

## Key facts

- **NCT ID:** NCT00862355
- **Lead sponsor:** Sun Pharma Advanced Research Company Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2010-12
- **Final completion:** 2011-01
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2019-05-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00862355

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00862355, "Bioequivalence Study of SPARC147609 in Patients With Ovarian Cancer". Retrieved via MORVS 2026-10-23 from https://api.morvs.ai/clinical/NCT00862355. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*